Transdermal dosage formulation

A excellent skin absorbability of citalopram, reduces skin irritation due citalopram providing percutaneous preparation having excellent safety. The present invention provides a percutaneous preparation for reducing skin irritation caused by citalopram, and at least one drug selected from the group consisting of citalopram and its pharmaceutically acceptable salt, triamcinolone acetonide, pivalate flumethasone, alclometasone propionate, at least one percutaneous preparation containing a steroid, a which clobetasone butyrate, selected from the group consisting of hydrocortisone butyrate, dexamethasone and prednisolone valerate acetate.